Evidence map›Paper›PMID 35822786›Full record

ArticleBiotech (Basel (Switzerland))2022

Prebiotic Potential and Value-Added Products Derived from

Vidya Sankarapandian, Kirubakaran Nitharsan, Kavitha Parangusadoss, Prakash Gangadaran, Prasanna Ramani, Balu Alagar Venmathi Maran, Manasi P Jogalekar

Open access · goldAbstract read
In one paragraph

Article in Biotech (Basel (Switzerland)), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Vidya SankarapandianDepartment of Microbiology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Trichy 620005, India.
Kirubakaran NitharsanDepartment of Microbiology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Trichy 620005, India.ORCID 0000-0003-1671-6305
Kavitha ParangusadossDepartment of Microbiology, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Trichy 620005, India.
Prakash GangadaranBK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Korea.ORCID 0000-0002-0658-4604
Prasanna RamaniDhanvanthri Laboratory, Department of Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Coimbatore 641112, India.ORCID 0000-0002-5236-7141
Balu Alagar Venmathi MaranBorneo Marine Research Institute, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, Malaysia.ORCID 0000-0003-1090-5295
Manasi P JogalekarUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA.
Bharathidasan University · INAmrita Vishwa Vidyapeetham · INKyungpook National University · KRUCSF Helen Diller Family Comprehensive Cancer Center · USUniversiti of Malaysia Sabah · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lately, microalgae-based value-added products have been gaining market value because they moderate the dependency on fossil fuel and high-value chemical products. To this end, the purpose of this study was to develop prebiotic products from the microalgae

Indexed as

biomasschlorophyllcyanobacteriaphycocyaninSpirulina laxissimavalue-added products

Identifiers

PMID35822786
PMCPMC9264395
OpenAlexW4224992061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.